IDM Pharma SA SA
IDM Pharma SA reported total assets of €2.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of IDM Pharma SA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -7 % Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IDM Pharma SA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
IDM Pharma SA's financial analysis
- Solvency71.1%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IDM Pharma SA
IDM Pharma SA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0870.495.618
- VAT number
- BE0870495618
- Peppol
- Registered · 0208:0870495618 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Dec 2004
- Registered office
- 5020 Namur
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
IDM Pharma SA (SA) has been based in Namur since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 177,465 € and equity of €1.46m; its revenue is not published. Its solvency stands at 71.1%, above the median of its sector (40.1%).
Companies similar to IDM Pharma SA
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Gerpinnes Pharma Retail sale of pharmaceutical products Gerpinnes · balance sheet €2.08m
- Stef DE MAN Retail sale of pharmaceutical products Sint-Truiden · balance sheet €2.02m
- GEOF Retail sale of pharmaceutical products Charleroi · balance sheet €2.10m
- Gans Investors Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet €1.97m
- Nicolas PUTOIS Retail sale of pharmaceutical products Chaudfontaine · balance sheet €2.14m
- Marjolein Vanderheyden Retail sale of pharmaceutical products Bocholt · balance sheet €2.14m
- Dstm Holding Retail sale of pharmaceutical products Léglise · balance sheet €2.14m
Frequently asked questions about IDM Pharma SA
What is the revenue of IDM Pharma SA?
IDM Pharma SA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IDM Pharma SA?
In Belgium, the VAT number is the company number prefixed with BE: BE0870495618 for IDM Pharma SA, if the company is VAT-registered. Its company number (CBE) is 0870.495.618.
Where is the registered office of IDM Pharma SA?
According to the CBE register, the registered office of IDM Pharma SA is in 5020 Namur.
What is the equity of IDM Pharma SA?
At the close of the 2025 financial year, the equity of IDM Pharma SA amounts to 1,459,637 €, a solvency of 71.1% of total assets.
Who manages IDM Pharma SA?
The register lists 2 active mandates at IDM Pharma SA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IDM Pharma SA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →